In a new study, researchers at the University of Maryland School of Medicine (UMSOM) have found that the gut microbiome appears to play a key role in how well the body accepts a transplanted heart. […]
Valbiotis, a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, confirms its international expansion with the appointment of Murielle Cazaubiel, founder and former Executive Director of Biofortis Mérieux […]
DNAnexus, the global leader in biomedical informatics and data management, today announced the winners of the Mosaic Community Challenge: Clinical Strain Detection, which evaluated the accuracy of microbial strain detection in metagenomic samples. The challenge […]
Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases (ILD). In a study at CHEST 2018, researchers at Beaumont Health Systems studied the influence of bacterial virulence on […]
Vedanta Biosciences announced preliminary results from the Phase 1a/1b clinical study in healthy volunteers for its lead, orally-administered live biotherapeutic product (LBP) candidate for recurrent Clostridium difficile infection (rCDI), VE303. With these Phase 1 data […]
On September 17, 2018 hopes were high regarding the clarification of the regulatory framework as well as a potential decision or ambitions by the FDA to stimulate further discussion regarding microbiome-based products, as the agency […]
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today announced the appointment of Aoife Brennan, M.B., B.Ch., as president and chief executive officer of Synlogic, […]
Following A-Mansia’s announcement of first close of Series A this April, Innovation Industries now joins the financing round of the microbiome company focused on developing products based on the unique properties of the Akkermansia muciniphila (A. […]
Second Genome, Inc., a clinical-stage company focused on the development of novel therapeutics identified through microbiome science, today announced the appointment of Karim Dabbagh, Ph.D., as president, chief executive officer, and a member of the […]
The DuPont Microbiome Venture and Global Health & Nutrition Science teams have worked in collaboration with the University of Virginia and 4Pharma Ltd in an experimental rhinovirus challenge to understand the role of nasal microbiota clusters and their […]
Microbiome Insights was a founding partner of the Microbiome Skin Health and Dermatology conference —held September 10th to 12th, 2018. The aim of this event was to explore ways of understanding the mechanisms underlying microbial interactions […]